Clinical Trials on Proteostasis Deficiencies in United Kingdom
Total 910 results
-
GlaxoSmithKlineTerminatedAmyloidosisUnited Kingdom
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineQuintiles, Inc.; Imperial College London; Royal Free Hospital NHS Foundation... and other collaboratorsCompleted
-
Eidos Therapeutics, a BridgeBio companyCompleted
-
GlaxoSmithKlineWithdrawn
-
GlaxoSmithKlineTerminatedAmyloidosisUnited Kingdom, United States
-
University of EdinburghCompleted
-
Alnylam PharmaceuticalsRecruitingTransthyretin-Mediated AmyloidosisUnited Kingdom
-
Alnylam PharmaceuticalsCompletedA Study of the Safety, Tolerability and Pharmacokinetics of ALN-TTR02 in Japanese Healthy VolunteersTransthyretin (TTR)-Mediated AmyloidosisUnited Kingdom
-
Alnylam PharmaceuticalsCompleted
-
Alnylam PharmaceuticalsCompletedTTR-mediated AmyloidosisUnited Kingdom
-
University College, LondonGlaxoSmithKline; Medical Research Council; University of OxfordCompleted
-
Alnylam PharmaceuticalsCompletedTTR-mediated AmyloidosisUnited States, United Kingdom
-
Alnylam PharmaceuticalsCompletedTransthyretin Mediated Amyloidosis (ATTR)United Kingdom, France, Portugal, Sweden
-
Dr Jorg TaubelRichmond Pharmacology Limited; National Amyloidosis CentreNot yet recruitingCardiac AmyloidosisUnited Kingdom
-
AstraZenecaRecruitingATTR AmyloidosisUnited Kingdom, United States, Denmark, Japan
-
Attralus, Inc.Novotech (Australia) Pty LimitedRecruitingAmyloidosis; SystemicUnited States, Australia, United Kingdom
-
Alnylam PharmaceuticalsCompletedTTR-mediated AmyloidosisUnited States, Canada, United Kingdom
-
Alnylam PharmaceuticalsCompletedTransthyretin-mediated Amyloidosis (ATTR Amyloidosis)United Kingdom
-
Janssen Research & Development, LLCRecruitingAmyloidosisCanada, Italy, United States, Greece, China, Netherlands, Spain, France, Germany, United Kingdom
-
Barbara Ann Karmanos Cancer InstituteRecruiting
-
Mayo ClinicCompletedAmyloidosisUnited States
-
Attralus, Inc.Active, not recruiting
-
Millennium Pharmaceuticals, Inc.Johnson & Johnson Pharmaceutical Research & Development, L.L.C.CompletedAmyloidosisUnited States
-
Tufts Medical CenterTerminated
-
University of Tennessee Graduate School of MedicineAttralus, Inc.RecruitingSystemic AmyloidosisUnited States
-
University of Tennessee Graduate School of MedicineCompletedSystemic AmyloidosisUnited States
-
Stanford UniversityCompleted
-
GE HealthcareMedpace, Inc.; i3 StatprobeCompleted
-
Medical College of WisconsinTerminatedCardiac AmyloidosisUnited States
-
Brigham and Women's HospitalTerminatedCardiac AmyloidosisUnited States
-
Brigham and Women's HospitalRecruiting
-
University of Tennessee Graduate School of MedicineActive, not recruitingSystemic AmyloidosisUnited States
-
The Cleveland ClinicAvid RadiopharmaceuticalsTerminatedCardiac AmyloidosisUnited States
-
C.T. Development America, Inc.CompletedAmyloidosisSpain, United States, Italy, Belgium, Netherlands, India, Tunisia, Latvia, Turkey, France, Germany, Estonia, Lithuania, Poland, Russian Federation, Georgia, United Kingdom, Israel, Egypt, Finland, Peru, Sweden, Ukraine
-
Alnylam PharmaceuticalsTerminatedAmyloidosis | Leukocyte Chemotactic Factor 2 AmyloidosisUnited States, Malaysia, United Kingdom, Mexico, Egypt, India
-
Mayo ClinicEnrolling by invitationCardiac AmyloidosisUnited States
-
Mayo ClinicCompletedTTR Cardiac AmyloidosisUnited States
-
Washington University School of MedicineCompleted
-
Columbia UniversityAttralus, Inc.RecruitingTransthyretin AmyloidosisUnited States
-
Lancashire Teaching Hospitals NHS Foundation TrustCompleted
-
Yale UniversityAlnylam Pharmaceuticals IncNot yet recruitingTransthyretin AmyloidosisUnited States
-
King's College Hospital NHS TrustManchester Metropolitan UniversityCompleted
-
Sheffield Teaching Hospitals NHS Foundation TrustUniversity of SheffieldCompleted
-
Oregon Health and Science UniversityAttralus, Inc.RecruitingAmyloidosis | Transthyretin AmyloidosisUnited States
-
Attralus, Inc.CompletedAmyloidosis; SystemicUnited States
-
Mayo ClinicRecruitingHealthy Adults | Amyloidosis CardiacUnited States